- Home
- Publications
- Publication Search
- Publication Details
Title
The Potential for EBV Vaccines to Prevent Multiple Sclerosis
Authors
Keywords
-
Journal
Frontiers in Neurology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-06-24
DOI
10.3389/fneur.2022.887794
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epstein-Barr virus and multiple sclerosis
- (2022) William H. Robinson et al. SCIENCE
- Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis
- (2022) Kjetil Bjornevik et al. SCIENCE
- Genetics and functional genomics of multiple sclerosis
- (2022) Woori Kim et al. Seminars in Immunopathology
- Is EBV the cause of multiple sclerosis?
- (2022) Gavin Giovannoni et al. Multiple Sclerosis and Related Disorders
- How does Epstein-Barr virus trigger MS?
- (2022) Vijay K. Kuchroo et al. IMMUNITY
- Epstein-Barr Virus and Systemic Autoimmune Diseases
- (2021) Gunnar Houen et al. Frontiers in Immunology
- DRB1–environment interactions in multiple sclerosis etiology: results from two Swedish case–control studies
- (2021) Anna Karin Hedström et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Zero-dose children and the immunisation cascade: Understanding immunisation pathways in low and middle-income countries
- (2021) Bianca de Oliveira Cata-Preta et al. VACCINE
- Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein–Barr Virus-Specific T Cell Therapy
- (2021) Zara A. Ioannides et al. Frontiers in Neurology
- Immunization with Epstein–Barr Virus Core Fusion Machinery Envelope Proteins Elicit High Titers of Neutralizing Activities and Protect Humanized Mice from Lethal Dose EBV Challenge
- (2021) Xinle Cui et al. Vaccines
- Changes to virus taxonomy and to the International Code of Virus Classification and Nomenclature ratified by the International Committee on Taxonomy of Viruses (2021)
- (2021) Peter J. Walker et al. ARCHIVES OF VIROLOGY
- Role of environmental factors in multiple sclerosis
- (2021) Amin Zarghami et al. Expert Review of Neurotherapeutics
- Clinical Correlation of Multiple Sclerosis Immunopathologic Subtypes
- (2021) W. Oliver Tobin et al. NEUROLOGY
- The Immune Response in Multiple Sclerosis
- (2021) Sofía Rodríguez Murúa et al. Annual Review of Pathology-Mechanisms of Disease
- Epstein–Barr virus posttransplant lymphoproliferative disorder: update on management and outcomes
- (2021) Julian Lindsay et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Molecular Basis of Epstein–Barr Virus Latency Establishment and Lytic Reactivation
- (2021) Takayuki Murata et al. Viruses-Basel
- Epigenetic control of the Epstein-Barr lifecycle
- (2021) Rui Guo et al. Current Opinion in Virology
- Cytotoxic CD4+ T-cells specific for EBV capsid antigen BORF1 are maintained in long-term latently infected healthy donors
- (2021) Alexander C. Dowell et al. PLoS Pathogens
- Kissing genetic MS risk loci to life
- (2021) Christian Münz EBioMedicine
- High Levels of Epstein–Barr Virus Nuclear Antigen-1-Specific Antibodies and Infectious Mononucleosis Act Both Independently and Synergistically to Increase Multiple Sclerosis Risk
- (2020) Anna Karin Hedström et al. Frontiers in Neurology
- Vaccination against the Epstein–Barr virus
- (2020) Julia Rühl et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Risk factors for Epstein Barr virus-associated cancers: a systematic review, critical appraisal, and mapping of the epidemiological evidence
- (2020) Deniz Bakkalci et al. Journal of Global Health
- Predictors of Epstein-Barr virus serostatus and implications for vaccine policy: A systematic review of the literature
- (2020) Joanne R Winter et al. Journal of Global Health
- A Pentavalent Epstein-Barr Virus-Like Particle Vaccine Elicits High Titers of Neutralizing Antibodies against Epstein-Barr Virus Infection in Immunized Rabbits
- (2020) Gabriela M. Escalante et al. Vaccines
- Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United Kingdom
- (2020) Ashvin Kuri et al. BMC PUBLIC HEALTH
- Attenuated immune control of Epstein Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA‐DR15
- (2020) Hana Zdimerova et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Progress in EBV Vaccines
- (2019) Dwain G. van Zyl et al. Frontiers in Oncology
- Immunization with Components of the Viral Fusion Apparatus Elicits Antibodies That Neutralize Epstein-Barr Virus in B Cells and Epithelial Cells
- (2019) Wei Bu et al. IMMUNITY
- Epithelial cell infection by Epstein-Barr virus
- (2019) Jia Chen et al. FEMS MICROBIOLOGY REVIEWS
- The promise of a prophylactic Epstein–Barr virus vaccine
- (2019) Henry H. Balfour et al. PEDIATRIC RESEARCH
- The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells
- (2018) Joana Machado-Santos et al. BRAIN
- Primary Epstein-Barr virus infection
- (2018) Samantha K. Dunmire et al. JOURNAL OF CLINICAL VIROLOGY
- Multiple Sclerosis
- (2018) Daniel S. Reich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multiple Sclerosis Pathology
- (2018) Hans Lassmann Cold Spring Harbor Perspectives in Medicine
- Epstein–Barr Virus and Cancer
- (2018) Paul J. Farrell Annual Review of Pathology-Mechanisms of Disease
- Response to ‘Seasonal variation of vitamin D and Epstein-Barr virus antibody in multiple sclerosis patients’, a comment letter regarding ‘Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients’
- (2018) S. Wergeland et al. EUROPEAN JOURNAL OF NEUROLOGY
- Multiple sclerosis - a review
- (2018) R. Dobson et al. EUROPEAN JOURNAL OF NEUROLOGY
- Programmed death 1 is highly expressed on CD8+ CD57+ T cells in patients with stable multiple sclerosis and inhibits their cytotoxic response to Epstein-Barr virus
- (2017) Maria T. Cencioni et al. IMMUNOLOGY
- Smoking Cessation and the Reduction of Disability Progression in Multiple Sclerosis: A Cohort Study
- (2017) Radu Tanasescu et al. NICOTINE & TOBACCO RESEARCH
- The Genetics of Multiple Sclerosis: From 0 to 200 in 50 Years
- (2017) Sergio E. Baranzini et al. TRENDS IN GENETICS
- The association between human endogenous retroviruses and multiple sclerosis: A systematic review and meta-analysis
- (2017) Elena Morandi et al. PLoS One
- The Safety and Immunological Effects of rAd5-EBV-LMP2 Vaccine in Nasopharyngeal Carcinoma Patients: A Phase I Clinical Trial and Two-Year Follow-Up
- (2016) Yongfeng Si et al. CHEMICAL & PHARMACEUTICAL BULLETIN
- Current multiple sclerosis treatments have improved our understanding of MS autoimmune pathogenesis
- (2016) Roland Martin et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Early T Cell Recognition of B Cells following Epstein-Barr Virus Infection: Identifying Potential Targets for Prophylactic Vaccination
- (2016) Jill M. Brooks et al. PLoS Pathogens
- Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site
- (2015) Masaru Kanekiyo et al. CELL
- Comprehensive serological profiling of human populations using a synthetic human virome
- (2015) G. J. Xu et al. SCIENCE
- Phase I trial of adoptively transferred tumor-infiltrating lymphocyte immunotherapy following concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma
- (2015) Jiang Li et al. OncoImmunology
- A Recombinant Modified Vaccinia Ankara Vaccine Encoding Epstein-Barr Virus (EBV) Target Antigens: A Phase I Trial in UK Patients with EBV-Positive Cancer
- (2014) G. S. Taylor et al. CLINICAL CANCER RESEARCH
- Multiple sclerosis: The elevated antibody response to Epstein–Barr virus primarily targets, but is not confined to, the glycine–alanine repeat of Epstein–Barr nuclear antigen-1
- (2014) Klemens Ruprecht et al. JOURNAL OF NEUROIMMUNOLOGY
- Viruses as potential pathogenic agents in systemic lupus erythematosus
- (2014) P Nelson et al. LUPUS
- Phase I Trial of Recombinant Modified Vaccinia Ankara Encoding Epstein-Barr Viral Tumor Antigens in Nasopharyngeal Carcinoma Patients
- (2013) E. P. Hui et al. CANCER RESEARCH
- Systematic Review and Meta-Analysis of the Sero-Epidemiological Association between Epstein Barr Virus and Multiple Sclerosis
- (2013) Yahya H. Almohmeed et al. PLoS One
- Seroprevalence of Epstein-Barr Virus Infection in U.S. Children Ages 6-19, 2003-2010
- (2013) Jennifer Beam Dowd et al. PLoS One
- Vitamin D Responsive Elements within the HLA-DRB1 Promoter Region in Sardinian Multiple Sclerosis Associated Alleles
- (2012) Eleonora Cocco et al. PLoS One
- A phase II study evaluating the safety and efficacy of an adenovirus-ΔLMP1-LMP2 transduced dendritic cell vaccine in patients with advanced metastatic nasopharyngeal carcinoma
- (2011) W. K. Chia et al. ANNALS OF ONCOLOGY
- Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections
- (2011) O. A. Odumade et al. CLINICAL MICROBIOLOGY REVIEWS
- A Virus-Like Particle-Based Epstein-Barr Virus Vaccine
- (2011) R. Ruiss et al. JOURNAL OF VIROLOGY
- Anti-Epstein–Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel
- (2011) KL Munger et al. Multiple Sclerosis Journal
- Primary infection with the epstein-barr virus and risk of multiple sclerosis
- (2010) Lynn I. Levin et al. ANNALS OF NEUROLOGY
- X-linked lymphoproliferative syndrome: a genetic condition typified by the triad of infection, immunodeficiency and lymphoma
- (2010) Nima Rezaei et al. BRITISH JOURNAL OF HAEMATOLOGY
- Environmental factors and their timing in adult-onset multiple sclerosis
- (2010) Adam E. Handel et al. Nature Reviews Neurology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now